tiprankstipranks
pc:aeror

AeroRx Therapeutics Inc

AeroRx Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary nebulized combination therapies for chronic respiratory diseases. Their lead product candidate, AERO-007, is the first potential nebulized LABA/LAMA fixed-dose combination drug in clinical development as a first-line maintenance therapy for chronic obstructive pulmonary disease (COPD). AeroRx aims to address the unmet needs of patients who are inadequately served by existing inhaler-based therapies. The company is also developing AERO-111, a potential nebulized LABA/LAMA/ICS triple therapy for patients requiring escalation beyond dual bronchodilators. AeroRx is based in La Jolla, California.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$21M
Total Amount Raised$21M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$21M
Latest Funding Amount$21M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Series A
$21.00M

Investors

Investor Name
Funding Round

Related News and Analysis